CHF69.20
0.20% today
SIX Swiss Exchange, Aug 12, 05:31 pm CET
ISIN
CH0432492467
Symbol
ALC

Alcon Stock price

CHF69.20
-0.52 0.75% 1M
-11.64 14.40% 6M
-7.70 10.01% YTD
-10.36 13.02% 1Y
+3.72 5.68% 3Y
+11.94 20.85% 5Y
+11.15 19.21% 10Y
+11.15 19.21% 20Y
SIX Swiss Exchange, Closing price Tue, Aug 12 2025
+0.14 0.20%
ISIN
CH0432492467
Symbol
ALC

Key metrics

Basic
Market capitalization
CHF34.5b
Enterprise Value
CHF37.6b
Net debt
CHF3.1b
Cash
CHF1.1b
Shares outstanding
494.6m
Valuation (TTM | estimate)
P/E
37.7 | 25.8
P/S
4.3 | 4.0
EV/Sales
4.7 | 4.4
EV/FCF
31.9
P/B
1.9
Dividends
DPS
CHF0.28
Yield 1Y | 5Y
0.4% | 0.3%
Growth 1Y | 5Y
16.7% | -
Payout 1Y | 3Y
16.9% | 19.2%
Increased
5 Years
Financials (TTM | estimate)
Revenue
CHF8.1b | CHF8.6b
EBITDA
CHF2.1b | CHF2.3b
EBIT
CHF1.1b | CHF1.7b
Net Income
CHF909.5m | CHF1.3b
Free Cash Flow
CHF1.2b
Growth (TTM | estimate)
Revenue
3.8% | 6.8%
EBITDA
7.1% | 9.4%
EBIT
12.1% | 55.9%
Net Income
6.9% | 60.1%
Free Cash Flow
87.0%
Margin (TTM | estimate)
Gross
54.3%
EBITDA
26.6% | 26.7%
EBIT
14.1%
Net
11.3% | 15.4%
Free Cash Flow
14.6%
Financial Health
Equity Ratio
71.0%
Return on Equity
4.7%
ROCE
4.9%
ROIC
4.3%
Debt/Equity
0.2
More
EPS
CHF1.8
FCF per Share
CHF2.4
Short interest
-
Employees
25k
Rev per Employee
CHF320.0k
Show more

Create a Free Account to create an Alcon alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Alcon Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Alcon forecast:

18x Buy
82%
4x Hold
18%

Analyst Opinions

22 Analysts have issued a Alcon forecast:

Buy
82%
Hold
18%

Financial data from Alcon

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
8,060 8,060
4% 4%
100%
- Direct Costs 3,688 3,688
7% 7%
46%
4,372 4,372
1% 1%
54%
- Selling and Administrative Expenses 2,648 2,648
1% 1%
33%
- Research and Development Expense 723 723
8% 8%
9%
2,141 2,141
7% 7%
27%
- Depreciation and Amortization 1,008 1,008
2% 2%
13%
EBIT (Operating Income) EBIT 1,134 1,134
12% 12%
14%
Net Profit 910 910
7% 7%
11%

In millions CHF.

Don't miss a Thing! We will send you all news about Alcon directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Alcon Stock News

marktEINBLICKE
5 months ago
Trotz Rückruf und schwachem Schlussquartal 2024 bleibt die Wachstumsperspektive intakt. Ist jetzt ein guter Einstiegszeitpunkt für Anleger bei Alcon?

Company Profile

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.

Head office Switzerland
CEO David Endicott
Employees 25,000
Founded 1945
Website www.alcon.ch

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today